These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21097845)

  • 1. CFTR transcription defects in pancreatic sufficient cystic fibrosis patients with only one mutation in the coding region of CFTR.
    Sheridan MB; Hefferon TW; Wang N; Merlo C; Milla C; Borowitz D; Green ED; Mogayzel PJ; Cutting GR
    J Med Genet; 2011 Apr; 48(4):235-41. PubMed ID: 21097845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis.
    Chu CS; Trapnell BC; Curristin SM; Cutting GR; Crystal RG
    J Clin Invest; 1992 Sep; 90(3):785-90. PubMed ID: 1381723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous spectrum of CFTR gene mutations in Korean patients with cystic fibrosis.
    Jung H; Ki CS; Koh WJ; Ahn KM; Lee SI; Kim JH; Ko JS; Seo JK; Cha SI; Lee ES; Kim JW
    Korean J Lab Med; 2011 Jul; 31(3):219-24. PubMed ID: 21779199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California.
    Salinas DB; Sosnay PR; Azen C; Young S; Raraigh KS; Keens TG; Kharrazi M
    PLoS One; 2016; 11(5):e0155624. PubMed ID: 27214204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis.
    Mickle JE; Macek M; Fulmer-Smentek SB; Egan MM; Schwiebert E; Guggino W; Moss R; Cutting GR
    Hum Mol Genet; 1998 Apr; 7(4):729-35. PubMed ID: 9499426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of a novel CFTR mutation P67S identified in a patient with atypical cystic fibrosis.
    Kraus C; Reis A; Naehrlich L; Dötsch J; Korbmacher C; Rauh R
    Cell Physiol Biochem; 2007; 19(5-6):239-48. PubMed ID: 17495464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.
    Ramalho AS; Beck S; Meyer M; Penque D; Cutting GR; Amaral MD
    Am J Respir Cell Mol Biol; 2002 Nov; 27(5):619-27. PubMed ID: 12397022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and functional analysis of the large 5' promoter region of CFTR gene revealed pathogenic mutations in CF and CFTR-related disorders.
    Giordano S; Amato F; Elce A; Monti M; Iannone C; Pucci P; Seia M; Angioni A; Zarrilli F; Castaldo G; Tomaiuolo R
    J Mol Diagn; 2013 May; 15(3):331-40. PubMed ID: 23470247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
    Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
    Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA-based detection of rare CFTR mutations improves genetic diagnosis of cystic fibrosis in populations with high genetic heterogeneity.
    Felício V; Ramalho AS; Igreja S; Amaral MD
    Clin Genet; 2017 Mar; 91(3):476-481. PubMed ID: 27174726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of a large heterozygous deletion and a splicing defect in the CFTR transcripts from nasal swab of a Japanese case of cystic fibrosis.
    Nakakuki M; Fujiki K; Yamamoto A; Ko SB; Yi L; Ishiguro M; Yamaguchi M; Kondo S; Maruyama S; Yanagimoto K; Naruse S; Ishiguro H
    J Hum Genet; 2012 Jul; 57(7):427-33. PubMed ID: 22572733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 32-bp deletion (2991del32) in the cystic fibrosis gene associated with CFTR mRNA reduction.
    Dörk T; Will K; Grade K; Krawczak M; Tümmler B
    Hum Mutat; 1994; 4(1):65-70. PubMed ID: 7524915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization studies of rare missense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) facilitate interpretation of genotype-phenotype relationships.
    Krasnov KV; Tzetis M; Cheng J; Guggino WB; Cutting GR
    Hum Mutat; 2008 Nov; 29(11):1364-72. PubMed ID: 18951463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis.
    Hamosh A; Trapnell BC; Zeitlin PL; Montrose-Rafizadeh C; Rosenstein BJ; Crystal RG; Cutting GR
    J Clin Invest; 1991 Dec; 88(6):1880-5. PubMed ID: 1721624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-gene CFTR sequencing combined with digital RT-PCR improves genetic diagnosis of cystic fibrosis.
    Straniero L; Soldà G; Costantino L; Seia M; Melotti P; Colombo C; Asselta R; Duga S
    J Hum Genet; 2016 Dec; 61(12):977-984. PubMed ID: 27488443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of cystic fibrosis in Lithuania: incomplete CFTR mutation detection by PCR-based screening protocols.
    Giannattasio S; Bobba A; Jurgelevicius V; Vacca RA; Lattanzio P; Merafina RS; Utkus A; Kucinskas V; Marra E
    Genet Test; 2006; 10(3):169-73. PubMed ID: 17020467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Genetics of Cystic Fibrosis Transmembrane Conductance Regulator: Genotype and Phenotype.
    Sosnay PR; Raraigh KS; Gibson RL
    Pediatr Clin North Am; 2016 Aug; 63(4):585-98. PubMed ID: 27469177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.